Silo Pharma, Psychedelic Stock Review, Roland Rick Perry

SILO Pharma (SILO) Gains 53%

For Now, Volatility Remains and the Traders, Seem to be Having the Most Fun. Silo Pharma Gains 53%...

Zappy Zapolin Hopes To Put Ibogaine Front And Center For Addiction

“The only legitimate addiction interrupter capable of breaking a heroin, meth, opiate, or alcohol addiction in a single 12-hour session.”

MindMed (MNMD) IPO on Nasdaq: Becomes Second Public Psychedelic Company.

InvestmentU By Amber Deter Apr 27, 2021 at 12:55PM The MindMed IPO is making...
Revive Therapeutics

Revive Therapeutics (RVVTF, RVV): Updates and News Archive.

Recent Headlines (See FDA Filing Submission at Bottom) LIVE QUOTE
cybin

Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright.

Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target.

Ehave (EHVVF) Announces Inclusion in the 2021 Psychedelic Investor Guide

MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic...
Zappy Zapolin, Chad Harman, Kevin Harrington, Psychedelic Stock Review

Psycheceutical’s (BWVI) Delivery Tech is Grabbing Attention. Will Pharma Listen?

A startup’s psychedelic delivery tech is grabbing attention. Will pharma listen? PharmaVoice Psycheceutical is developing a back-of-the-neck topical treatment...

Huge News at Ehave Inc.(EHVVF), our Favorite Psychedelic.

We just finished compiling the 2021 Psychedelic Investor Guide and reviewed 44 companies - in all shapes and sizes. Excluding Johnson &...

Psycheceutical Bioscience (BWVI) Secures Funding for Clinical Trials

Psycheceutical Secures Funding for Clinical Trials of NeuroDirect™ Ketamine Topical to Treat PTSD. Company raises $1.3M USD convertible note...
Revive Therapeutics

Revive Therapeutics (RVVTF) Moves a Step Closer to FDA Verdict for Its Novel Covid...

Two Binary Events Directly Ahead. As in Months Away, not Years. Share Price up 76% During April.

Latest article

Nine Page Summary Report on GeoVax (GOVX)

This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...